The role of the Australian Adverse Drug Reactions Advisory Committee (ADRAC) in monitoring drug safety
- 27 June 2002
- journal article
- Published by Elsevier in Toxicology
- Vol. 181-182, 99-102
- https://doi.org/10.1016/s0300-483x(02)00262-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacotherapeutics: what a difference five decades makes!The Medical Journal of Australia, 2001
- Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its developmentJournal of Clinical Epidemiology, 2000
- Flucloxacillin hepatitis – an Australian epidemicAustralian and New Zealand Journal of Medicine, 1995
- Augmentin‐associated jaundiceThe Medical Journal of Australia, 1994
- Tiaprofenic acid as a cause of non‐bacterial cystitisThe Medical Journal of Australia, 1994
- Fatal royal jelly‐Induced asthmaThe Medical Journal of Australia, 1994
- Risk factors for development of flucloxacillin associated jaundice.BMJ, 1993
- Glucomannan and risk of oesophageal obstruction.BMJ, 1986
- Mianserin: A Possible Cause of Neutropenia and AgranulocytosisThe Medical Journal of Australia, 1980